Abstract
Introduction Prolonged or recurrent cough is a common reason for referral to pediatric pulmonologists, yet few studies have assessed its causes. We examined records of children visiting respiratory outpatient clinics in Switzerland and assessed how diagnoses vary by age.
Methods We analyzed data from the multicenter Swiss Paediatric Airway Cohort study. We included 363 children (median age 6 years, range 0–16) referred for prolonged or recurrent cough. From outpatient records, we extracted information on diagnostic investigations, final diagnoses proposed by pediatric pulmonologists, and treatments prescribed.
Results Asthma and asthma-like conditions (cough variant asthma, episodic viral wheeze, and recurrent obstructive bronchitis) was diagnosed in 132 (36%) of 363 children, respiratory tract infections (RTI) including protracted bacterial bronchitis (PBB) in 51 (14%), upper airway cough syndrome (UACS) in 48 (13%), postinfectious cough in 36 (10%); other diagnoses including gastroesophageal reflux disease (GERD) and somatic cough syndrome or tic cough were found in 23 (6%). No etiology was found in 73 children (20%). Asthma was diagnosed 3.5 times more often in schoolchildren while RTI including PBB was diagnosed 3 times more often in preschoolers. Inhaled corticosteroids were prescribed for 84% of children diagnosed with asthma and asthma-like conditions, antibiotics for 43% of children with RTI, and nasal corticosteroids for 83% of those with UACS.
Conclusion Coughing children received a wide spectrum of diagnoses that differed between preschool and schoolchildren. Asthma accounted for 36% of diagnoses, which emphasizes the importance of comprehensive investigation beyond asthma in children with prolonged or recurrent cough.
Competing Interest Statement
MCM, AE, SG, TK, CDJ, BK, OS, ESLP and CK have nothing to disclose. AM reports personal fees from Vertex, OM Pharma, Astra Zeneca, and grants from Vertex-all outside the submitted work. NR reports personal fees from OM Pharma, Schwabe Pharma, Vertex, and Sanofi-all outside the submitted work. JU reports personal fees from Vertex, Zurich Lung Foundation, and Careum Education Zurich, travel fees from Vertex, and grants from Swiss Lung Foundation, Zurich Lung Foundation, Palatin Foundation (Basel, Switzerland) and Swiss Cancer Research-all outside the submitted work.
Funding Statement
This study was funded by the Swiss National Science Foundation (SNF Grants: SNF 320030_182628 & SNF 320030_212519) and the Swiss Personalized Health Network (Project DEM-2022-17: Using routine health care data to facilitate cohort studies (SPHN-SPAC))
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Bern Cantonal Ethics Committee (Kantonale Ethikkommission Bern 2016-02176) approved the study; written informed consent was obtained from parents and patients aged ≥ 14 years.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
(maria.mallet{at}unibe.ch), (annina.elmiger{at}students.unibe.ch), (sarah.glick{at}unibe.ch), (tayisiya.krasnova{at}unibe.ch), (carmen.dejong{at}insel.ch), (barbara.kern{at}ksa.ch), (Alexander.Moeller{at}kispi.uzh.ch), (nicolas.regamey{at}luks.ch), (HESO1{at}gmx.ch), (Jakob.Usemann{at}ukbb.ch), (eva.pedersen{at}unibe.ch), (claudia.kuehni{at}unibe.ch)
Ethical statement The Bern Cantonal Ethics Committee (Kantonale Ethikkommission Bern 2016-02176) approved the study; written informed consent was obtained from parents and patients aged ≥ 14 years.
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available on reasonable request from the corresponding author.
